“…The lung can develop strong, organ-specific antimicrobial activity while at the same time limiting the potential damage inflicted on the lung parenchyma by subsequent inflammatory processes. IDO has antimicrobial properties against a variety of intracellular pathogens, such as parasites (e.g., Toxoplasma gondii) (37), bacteria (e.g., Listeria monocytogenes) (38), mycobacteria (e.g., Mycobacterium avium) (12), and viruses (e.g., cytomegalovirus) (39). The inhibition of intracellular growth of these microorganisms can occur (a) by depletion of intracellular levels of the rarest amino acid, trp, which is essential for their growth, and/or (b) by the generation of antimicrobial trp metabolites.…”